CN Patent

CN117069735A — 一种高效合成瑞卢戈利的方法和其应用

Assigned to Beijing Sea Source Medical Science And Technology Co ltd · Expires 2023-11-17 · 3y expired

What this patent protects

本发明涉及药物合成领域，具体涉及一种高效合成瑞卢戈利的方法和其应用。本发明提供的瑞卢戈利或其药学上可接受的盐的制备方法，将化合物S3与甲氧基胺衍生物在缩合剂的作用下缩合制得。本发明提供的瑞卢戈利的制备方法收率高，纯度好，后处理方便，仅洗涤即可得到高纯度产物，具有操作简便，工艺稳定可控、适合于大规模工业化生产等优势。

USPTO Abstract

本发明涉及药物合成领域，具体涉及一种高效合成瑞卢戈利的方法和其应用。本发明提供的瑞卢戈利或其药学上可接受的盐的制备方法，将化合物S3与甲氧基胺衍生物在缩合剂的作用下缩合制得。本发明提供的瑞卢戈利的制备方法收率高，纯度好，后处理方便，仅洗涤即可得到高纯度产物，具有操作简便，工艺稳定可控、适合于大规模工业化生产等优势。

Drugs covered by this patent

Patent Metadata

Patent number
CN117069735A
Jurisdiction
CN
Classification
—
Expires
2023-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Sea Source Medical Science And Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.